<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Turk J Haematol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Turk J Haematol</journal-id>
      <journal-id journal-id-type="publisher-id">TJH</journal-id>
      <journal-title-group>
        <journal-title>Turkish Journal of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1300-7777</issn>
      <issn pub-type="epub">1308-5263</issn>
      <publisher>
        <publisher-name>Galenos Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26377049</article-id>
      <article-id pub-id-type="pmc">4805318</article-id>
      <article-id pub-id-type="doi">10.4274/tjh.2014.0416</article-id>
      <article-id pub-id-type="publisher-id">1571</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Hemophagocytic Lymphohistiocytosis Case with Newly Defined UNC13D (c.175G&gt;C; p.Ala59Pro) Mutation and a Rare Complication</article-title>
        <trans-title-group xml:lang="tr">
          <trans-title>Yeni Tan&#x131;mlanan UNC13D (c.175G&gt;C; p.Ala59Pro) Mutasyonlu Hemofagositik Lenfohistiositozlu Bir Hasta ve Nadir Komplikasyon</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>I&#x15F;&#x131;k Balc&#x131;</surname>
            <given-names>Yasemin</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#xD6;zg&#xFC;rler Akp&#x131;nar</surname>
            <given-names>Funda</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Polat</surname>
            <given-names>Aziz</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kenar</surname>
            <given-names>Fethullah</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tesi</surname>
            <given-names>Bianca</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Greenwood</surname>
            <given-names>Tatiana</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yal&#xE7;&#x131;n</surname>
            <given-names>Nagihan</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ko&#xE7;yi&#x11F;it</surname>
            <given-names>Ali</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>
Pamukkale University Faculty of Medicine, Department of Pediatric Hematology, Denizli, Turkey
</aff>
      <aff id="A2"><label>2</label>
Pamukkale University Faculty of Medicine, Department of Pediatrics, Denizli, Turkey
</aff>
      <aff id="A3"><label>3</label>
Pamukkale University Faculty of Medicine, Department of Otorhinolaryngology, Denizli, Turkey
</aff>
      <aff id="A4"><label>4</label>
Karolinska University Hospital Huddinge, Stockholm, Sweden
</aff>
      <aff id="A5"><label>5</label>
Pamukkale University Faculty of Medicine, Department of Pathology, Denizli, Turkey
</aff>
      <aff id="A6"><label>6</label>
Pamukkale University Faculty of Medicine, Department of Radiology, Denizli, Turkey
</aff>
      <author-notes>
        <corresp id="COR1">* Address for Correspondence: Pamukkale University Faculty of Medicine, Department of Pediatric Hematology, Denizli, Turkey GSM: +90 532 547 71 79 E-mail: <email>dryibalci@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>3</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <volume>32</volume>
      <issue>4</issue>
      <fpage>355</fpage>
      <lpage>358</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>10</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Turkish Journal of Hematology, Published by Galenos Publishing.&#xD;
</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Hemophagocytic lymphohistiocytosis (HLH) represents a severe hyperinflammatory condition with cardinal symptoms of prolonged fever, cytopenias, hepatosplenomegaly, and hemophagocytosis by activated, morphologically benign macrophages with impaired function of natural killer cells and cytotoxic T lymphocytes. A 2-month-old girl, who was admitted with fever, was diagnosed with HLH and her genetic examination revealed a newly defined mutation in the UNC13D (c.175G&gt;C; p.Ala59Pro) gene. She was treated with dexamethasone, etoposide, and intrathecal methotrexate. During the second week of treatment, after three doses of etoposide, it was noticed that there was a necrotic plaque lesion on the soft palate. Pathologic examination of debrided material in PAS and Grocott staining revealed lots of septated hyphae, which was consistent with aspergillosis infection. Etoposide was stopped and amphotericin B treatment was given for six weeks. HLH 2004 protocol was completed to eight weeks with cyclosporine A orally. There was no patient with invasive aspergillosis infection as severe as causing palate and nasal septum perforation during HLH therapy. In immuncompromised patients, fungal infections may cause nasal septum perforation and treatment could be achieved by antifungal therapy and debridement of necrotic tissue.</p>
      </abstract>
      <trans-abstract xml:lang="tr">
        <p>Hemofagositik lenfohistiositoz (HLH) uzam&#x131;&#x15F; ate&#x15F;, sitopeni, hepatosplenomegali semptomlar&#x131; ile seyreden, active olmu&#x15F;, morfolojik olarak benign makrofaj ve do&#x11F;al &#xF6;ld&#xFC;r&#xFC;c&#xFC; h&#xFC;creler ile sitotosik T lenfosit fonksiyon bozuklu&#x11F;u sonucu geli&#x15F;en hiperenflamatuvar bir durumdur. &#x130;ki ayl&#x131;k d&#xFC;&#x15F;meyen ate&#x15F; yak&#x131;nmas&#x131; ile ba&#x15F;vuran hasta HLH tan&#x131;s&#x131; ald&#x131; ve hastan&#x131;n genetik incelemesinde UNC13D (c.175G&gt;C; p.Ala59Pro) geninde yeni tan&#x131;mlanan bir mutasyon saptand&#x131;. Hastaya deksamatazon, etopozit ve intratekal metotreksat tedavileri ba&#x15F;land&#x131;. Tedavinin 2. haftas&#x131;nda, &#xFC;&#xE7; doz etopozit ald&#x131;ktan sonra, yumu&#x15F;ak damakta plak lezyonu fark edildi ve bu nekrotik lezyon debride edildi. Debridman materyalinin patolojik incelemesinin PAS, Grocott boyamas&#x131;nda aspergilloz enfeksiyonu ile uyumlu olarak &#xE7;ok say&#x131;da septal&#x131; hif g&#xF6;r&#xFC;ld&#xFC;. Etopozid tedavisi sonland&#x131;r&#x131;larak alt&#x131; hafta boyunca amphotericin B tedavisi verildi. HLH 2004 tedavi protokol&#xFC; oral siklosporin ile sekiz haftaya tamamland&#x131;. HLH tedavisi s&#x131;ras&#x131;nda yumu&#x15F;ak damak perforasyonuna neden olacak kadar a&#x11F;&#x131;r aspergilloz enfeksiyonu ge&#xE7;iren bir olgu bildirilmemi&#x15F;tir. &#x130;mm&#xFC;nyetmezlikli hastada mantar enfeksiyonlar&#x131; nazal septum perforasyonuna neden olabilmektedir ve tedavi nekrotik dokunun debridman&#x131; ve antifungal tedavi ile sa&#x11F;lanabilmektedir.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Hemophagocytic lymphohistiocytosis</kwd>
        <kwd>Invasive aspergillosis infection</kwd>
        <kwd>UNC13D (c.175G&gt;C; p.Ala59Pro)</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>INTRODUCTION</title>
      <p>Hemophagocytic lymphohistiocytosis (HLH) is a severe life-threatening disease precipitated by secretion of cytokines from morphologically benign macrophages, which ends with uncontrolled hyperinflammation with prolonged fever, cytopenias, hepatosplenomegaly, and hemophagocytosis. Elevation of triglycerides, ferritin, lactate dehydrogenase, and transaminase levels and decreases in fibrinogen levels are characteristic findings [<xref rid="ref1" ref-type="bibr">1</xref>]. Impaired cytotoxic function of T cells and natural killer cells is a known cause of familial forms of HLH. The HLH-2004 protocol with immunomodulatory and cytotoxic drugs is used for treatment of patients with HLH [<xref rid="ref2" ref-type="bibr">2</xref>]. Importantly, invasive infections have been reported in up to 56% of children with HLH on chemotherapy, with invasive fungal infections causing 50% of deaths among such cases [<xref rid="ref3" ref-type="bibr">3</xref>].</p>
      <p>Here we report an unusual aspergillosis infection with palate and nasal septum perforation following chemotherapy in a patient with familial HLH with a novel mutation in UNC13D. Notably, the fungal infection in our patient was treated successfully with antifungal therapy and surgical debridement.</p>
    </sec>
    <sec id="S2">
      <title>CASE PRESENTATION</title>
      <p>A 2-month-old girl, born subsequent to a term gestation with unrelated parents and an unremarkable previous history, was referred to our clinic with unremitting fever since 1 month despite repeated intravenous administrations of antibiotics. There was no history of sibling death in her family. On admission, vital signs were normal except body temperature of 38.7 &#xB0;C. The patient was pale with petechial rashes on the lower extremities. She displayed hepatomegaly (6 cm below costal margin) and splenomegaly (3 cm below costal margin). Informed consent was obtained.</p>
      <p>The patient&#x2019;s laboratory findings were as follows; hemoglobin: 63 g/L, mean corpuscular volume (MCV): 88.9 fL, total leukocyte count: 2.84x109/L, thrombocyte count: 10x109/L, alanine aminotransferase (ALT): 50 IU/L, aspartate aminotransferase (AST): 62 IU/L, total bilirubin: 0.58 mg/dL, direct bilirubin: 0.7 mg/dL, gamma glutamyl transferase: 328 U/L, albumin: 2.9 g/dL, ferritin: 2000 ng/mL, triglyceride: 617 mg/dL, LDL cholesterol: 11 mg/dL, HDL cholesterol: 7 mg/dL, lactate dehydrogenase: 379 U/L, uric acid: 2.3 mg/dL, fibrinogen: 107 mg/dL. Her renal function tests and electrolytes were normal. Her peripheral smear revealed 4% neutrophils, 90% lymphocytes, and 6% monocytes. Absolute neutrophil count was 0.113x109/L. No hemolysis or blasts were visible in her peripheral blood smear. Her transaminase levels increased on the third day of administration (AST: 280 IU/L, ALT: 265 IU/L). Serological studies for infection with Epstein-Barr virus, parvovirus B19, cytomegalovirus, Toxoplasma gondii, rubella, Leishmania, and hepatitis were all negative. Natural killer cell activity and soluble IL-2 level could not be analyzed. Numerous histiocytes showing hemophagocytosis were observed in the bone marrow aspiration smears.</p>
      <p>Conclusively, the patient fulfilled a required 5 out of 6 examined diagnostic criteria for the diagnosis of HLH [<xref rid="ref1" ref-type="bibr">1</xref>]. Accordingly, the patient was treated with the HLH-2004 protocol with dexamethasone, etoposide, and cyclosporine A. Mutation analyses, identifying a novel homozygous variant in UNC13D (c.175G&gt;C; p.Ala59Pro), confirmed a diagnosis of familial HLH. The variant was not found in the healthy population (1000 Genomes database), and it was predicted as possibly damaging by PolyPhen-2 but as tolerated by sorting tolerant from intolerant (SIFT). The father was a heterozygous carrier of the mutation, while the mother could not be tested.</p>
      <p>During the second week of treatment, after 3 doses of etoposide at 150 mg/m2/dose, a grossly necrotic soft tissue lesion was noticed on the soft palate and was successfully excised (<xref ref-type="fig" rid="f1">Figure 1</xref>). During the operation an oronasal fistula was revealed, as well as a perforation of the caudal side of the nasal septum along with an abscess formation in the left vestibular floor. Although there was no microbial growth in the necrotic material, microscopic examination of the debrided material in PAS and Grocott staining showed abundant septatedhyphae, consistent with aspergillosis infection (<xref ref-type="fig" rid="f2">Figure 2</xref>). Etoposide was stopped and amphotericin B treatment was given for 6 weeks at a dosage of 3.5 mg/kg/day. The HLH-2004 protocol was followed for 8 weeks with cyclosporine A and dexamethasone orally.</p>
      <p>At the most recent follow-up, after 4 months, the patient still presented with a 2-cm hepatosplenomegaly, while her soft palate had successfully epithelialized. However, there is a permanent deformity of her nose. Her laboratory findings were as follows; hemoglobin: 103 g/L, MCV: 77.7 fL, total leukocyte count: 15,280x109/L, thrombocytes: 230,000x109/L, ALT: 32 IU/L, AST: 12 IU/L, ferritin: 916 ng/mL, triglyceride: 421 mg/dL, LDL cholesterol: 78 mg/dL, HDL cholesterol: 20 mg/dL, lactate dehydrogenase: 226 U/L, uric acid: 1.7 mg/dL, fibrinogen: 233 mg/dL. Until bone marrow transplantation she was treated with oral cyclosporine A (at the HLH-2004 protocol dosage), trimethoprim sulfamethoxazole, and fluconazole.</p>
    </sec>
    <sec id="s3">
      <title>DISCUSSION AND REVIEW OF THE LITERATURE</title>
      <p>Herein we describe the disease course of a patient carrying a novel homozygous UNC13D mutation. Familial HLH cases typically have an earlier presentation, with infectious agents including herpes viruses such as the Epstein-Barr virus precipitating disease. However, in our case, we did not detect an infectious etiological agent. For treatment, chemoimmunotherapy (etoposide, dexamethasone, cyclosporine A, and, for selected patients, intrathecal methotrexate or corticosteroids) is recommended, but for severe disease or familial cases hemopoietic stem cell transplantation is life saving [<xref rid="ref4" ref-type="bibr">4</xref>].</p>
      <p>Opportunistic infections are a common complication of immunosuppression caused by cytotoxic treatment of the disease and by the disease itself. As our case illustrates, HLH patients have a potential risk of developing invasive fungal infections that can be severe. Aspergillus species have emerged as an important cause of life-threatening infections in immunocompromised patients. Highlighting the severity of invasive fungal infections, 6/12 (50%) fatal cases in a study cohort of 18 children with primary HLH were reported to be caused by invasive fungal infections, of which 2 cases were diagnosed with invasive Aspergillus infection first at autopsy [<xref rid="ref5" ref-type="bibr">5</xref>].</p>
      <p>Aspergillus can differentiate into hyphal forms that produce toxins damaging epithelial tissue, leading to invasion of connective and vascular tissue by the fungi, which subsequently can result in thrombosis and ultimately necrosis of hard and soft tissues with perforation. Systemic antifungal therapy and surgical resection or debridement is important for the management of invasive sinonasalaspergillosis. Amphotericin B, voriconazole, and caspofungincan be considered for antifungal therapy [<xref rid="ref5" ref-type="bibr">5</xref>]. Our case was treated successfully with surgical debridement and 6 weeks of amphotericin B treatment.</p>
      <p>In the English literature, the case of a 15-year-old boy who developed fungal infection with nasal septal perforation after bone marrow transplantation for acute myeloid leukemia was reported. He was also treated successfully with surgical debridement and amphotericin B [<xref rid="ref6" ref-type="bibr">6</xref>].</p>
      <p>Our report represents an interesting case of familial HLH caused by a novel homozygous UNC13D mutation and affected by invasive sinonasal aspergillosis.</p>
      <p>The UNC13D gene encodes for the Munc13-4 protein, a critical effector of the exocytosis of cytotoxic granules priming cytotoxic granule fusion. Munc13-4 deficiency impairs the delivery of the effector proteins, perforin and granzymes, into the target cells, resulting in defective cellular cytotoxicity and a clinical picture that appears very similar to that of FHL-2 [<xref rid="ref7" ref-type="bibr">7</xref>]. UNC13D mutations are present in almost 30%-40% of familial HLH cases [<xref rid="ref8" ref-type="bibr">8</xref>].</p>
      <p>To the best of our knowledge, no c.175G&gt;C; p.Ala59Pro mutation in UNC13D has been presented before in the literature. This novel mutation may be responsible for our patient&#x2019;s severe clinical condition. However, to compare the mutation type and clinical course, there is a need for clinical studies.</p>
      <p>We want to emphasize the importance of awareness of the occurrence of potentially life-threatening invasive fungal infections in patients with HLH. Furthermore, this highlights the efficacy of surgical debridement and amphotericin B for successful treatment of fungal infections with focal lesions.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="FN3" fn-type="con">
        <p><bold>Informed Consent</bold>: Informed consent was obtained, <bold>Concept:</bold> Aziz Polat, <bold>Design:</bold> Yasemin I&#x15F;&#x131;k Balc&#x131;, Data <bold>Collection or Processing:</bold> Funda &#xD6;zg&#xFC;rler Akp&#x131;nar, <bold>Analysis or Interpretation:</bold> Bianca Tesi, Tatiana Greenwood, Fethullah Kenar, <bold>Literature Search:</bold> Funda &#xD6;zg&#xFC;rler Akp&#x131;nar, <bold>Writing:</bold> Funda &#xD6;zg&#xFC;rler Akp&#x131;nar, Bianca Tesi.</p>
      </fn>
      <fn id="FN1" fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Janka</surname>
              <given-names>GE</given-names>
            </name>
          </person-group>
          <article-title>Hemophagocytic syndromes</article-title>
          <source>Blood Rev</source>
          <year>2007</year>
          <volume>21</volume>
          <fpage>245</fpage>
          <lpage>253</lpage>
          <pub-id pub-id-type="pmid">17590250</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Henter</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Horne</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Arico</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Horne</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aric&#xF3;</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Egeler</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Filipovich</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Imashuku</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ladisch</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>McClain</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Winiarski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Janka</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis</article-title>
          <source>Pediatr Blood Cancer</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>124</fpage>
          <lpage>131</lpage>
          <pub-id pub-id-type="pmid">16937360</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Sung</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Weitzman</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Petric</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>The role of infections in primary hemophagocytic lymphohistiocytosis: a case series and review of the literature</article-title>
          <source>Clin Infect Dis</source>
          <year>2001</year>
          <volume>33</volume>
          <fpage>1644</fpage>
          <lpage>1648</lpage>
          <pub-id pub-id-type="pmid">11595993</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Horne</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Janka</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Maarten Egeler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gadner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Imashuku</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ladisch</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Locatelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Montgomery</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Winiarski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Filipovich</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis</article-title>
          <source>Br J Haematol</source>
          <year>2005</year>
          <volume>129</volume>
          <fpage>622</fpage>
          <lpage>630</lpage>
          <pub-id pub-id-type="pmid">15916685</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Walsh</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Anaissie</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Denning</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Herbrecht</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kontoyiannis</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Marr</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Morrison</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Segal</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Steinbach</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Burik</surname>
              <given-names>JA</given-names>
              <suffix>van</suffix>
            </name>
            <name>
              <surname>Wingard</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <name>
            <surname>Patterson</surname>
            <given-names>TF;</given-names>
          </name>
          <collab>Infectious Diseases Society of America</collab>
          <article-title>Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America</article-title>
          <source>Clin Infect Dis</source>
          <year>2008</year>
          <volume>46</volume>
          <fpage>327</fpage>
          <lpage>360</lpage>
          <pub-id pub-id-type="pmid">18177225</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Shannon</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Sclaroff</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Colm</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Invasive aspergillosis of the maxilla in an immunocompromised patient</article-title>
          <source>Oral Surg Oral Med Oral Pathol</source>
          <year>1990</year>
          <volume>70</volume>
          <fpage>425</fpage>
          <lpage>427</lpage>
          <pub-id pub-id-type="pmid">2120652</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Cetica</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pende</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Griffiths</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Aric&#xF2;</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Molecular basis of familial hemophagocytic lymphohistiocytosis</article-title>
          <source>Haematologica</source>
          <year>2010</year>
          <volume>95</volume>
          <fpage>538</fpage>
          <lpage>541</lpage>
          <pub-id pub-id-type="pmid">20378576</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Sieni</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cetica</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hackmann</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Coniglio</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Da Ros</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ciambotti</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pende</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Griffiths</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Aric&#xF2;</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning</article-title>
          <source>Front Immunol</source>
          <year>2014</year>
          <volume>5</volume>
          <fpage>167</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="pmid">24795715</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title>Partial perforation in septal cartilage.</title>
      </caption>
      <graphic xlink:href="TJH-32-355-g1"/>
    </fig>
    <fig id="f2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <title>Septated hyphae with 45&#xB0; angle branching in aspergillosis (Grocott, 100x).</title>
      </caption>
      <graphic xlink:href="TJH-32-355-g2"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
